REVIEW PAPER
Oxidative stress and age-related changes in T cells: is thalassemia a model of accelerated immune system aging?
Submission date: 2015-05-14
Final revision date: 2015-06-19
Acceptance date: 2015-07-20
Publication date: 2016-01-20
Cent Eur J Immunol 2016;41(1):116-124
KEYWORDS
ABSTRACT
Iron overload in β-thalassemia major occurs mainly due to blood transfusion, an essential treatment for β-thalassemia major patients, which results in oxidative stress. It has been thought that oxidative stress causes elevation of immune system senescent cells. Under this condition, cells normally enhance in aging, which is referred to as premature immunosenescence. Because there is no animal model for immunosenescence, most knowledge on the immunosenescence pattern is based on induction of immunosenescence. In this review, we describe iron overload and oxidative stress in β-thalassemia major patients and how they make these patients a suitable human model for immunosenescence. We also consider oxidative stress in some kinds of chronic virus infections, which induce changes in the immune system similar to β-thalassemia major. In conclusion, a therapeutic approach used to improve the immune system in such chronic virus diseases, may change the immunosenescence state and make life conditions better for β-thalassemia major patients.
REFERENCES (129)
1.
Politou M, Kalotychou V, Pissia M, et al. (2004): The impact of the mutations of the HFE gene and of the SLC11A3 gene on iron overload in Greek thalassemia intermedia and beta(s)/beta(thal) anemia patients. Haematologica 89: 490-492.
2.
Rachmilewitz EA, Weizer-Stern O, Adamsky K, et al. (2005): Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants? Ann N Y Acad Sci 1054: 118-123.
3.
Kakhlon O, Cabantchik ZI (2002): The labile iron pool: characterization, measurement, and participation in cellular processes. Free Radic Biol Med 33: 1037-1046.
4.
Breuer W, Hershko C, Cabantchik ZI (2002): The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci 23: 185-192.
5.
Aisen P, Enns C, Wessling-Resnick M (2001): Chemistry and biology of eukaryotic iron metabolism. Int J Biochem Cell Biol 33: 940-959.
6.
Esposito BP, Breuer W, Sirankapracha P, et al. (2003): Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 102: 2670-2677.
7.
Farina M, Avila DS, da Rocha JB, Aschner M (2013): Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury. Neurochem Int 62: 575-594.
8.
Cighetti G, Duca L, Bortone L, et al. (2002): Oxidative status and malondialdehyde in beta-thalassaemia patients. Eur J Clin Invest 32 Suppl 1: 55-60.
9.
Campanella A, Rovelli E, Santambrogio P, et al. (2009): Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia. Hum Mol Genet 18: 1-11.
10.
Nunez MT, Urrutia P, Mena N, et al. (2012): Iron toxicity in neurodegeneration. Biometals 25: 761-776.
11.
Brissot P, Ropert M, Le Lan C, Loreal O (2012): Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta 1820: 403-410.
12.
Porter JB, Garbowski M (2014): The pathophysiology of transfusional iron overload. Hematol Oncol Clin North Am 28: 683-701.
13.
Wu D, Cederbaum AI. Alcohol, oxidative stress, and free radical damage. Alcohol Res Health 2003; 27: 277-284.
14.
Walter PB, Fung EB, Killilea DW, et al. (2006): Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 135: 254-263.
15.
Scott MD (2006): H2O2 injury in beta thalassemic erythrocytes: protective role of catalase and the prooxidant effects of GSH. Free Radic Biol Med 40: 1264-1272.
16.
Meral A, Tuncel P, Surmen-Gur E, et al. (2000): Lipid peroxidation and antioxidant status in beta-thalassemia. Pediatr Hematol Oncol 17: 687-693.
17.
Roy N, Stoyanova T, Dominguez-Brauer C, et al. (2010): DDB2, an essential mediator of premature senescence. Mol Cell Biol 30: 2681-2692.
18.
Shay JW, Wright WE (2000): Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol 1: 72-76.
19.
Bekaert S, De Meyer T, Van Oostveldt P (2005): Telomere attrition as ageing biomarker. Anticancer Res 25: 3011-3021.
20.
Sitte N, Merker K, Von Zglinicki T, et al. (2000): Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part II – aging of nondividing cells. FASEB J 14: 2503-2510.
21.
Serrano M, Blasco MA (2001): Putting the stress on senescence. Curr Opin Cell Biol 13: 748-753.
22.
Samani KG, Farrokhi E (2014): Effects of cumin extract on oxLDL, paraoxanase 1 activity, FBS, total cholesterol, triglycerides, HDL-C, LDL-C, Apo A1, and Apo B in in the patients with hypercholesterolemia. Int J Health Sci (Qassim) 8: 39.
23.
Parrinello S, Samper E, Krtolica A, et al. (2003): Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 5: 741-747.
24.
Kawanishi S, Hiraku Y, Oikawa S (2001): Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging. Mutat Res 488: 65-76.
25.
Hamilton ML, Van Remmen H, Drake JA, et al. (2001): Does oxidative damage to DNA increase with age? Proc Natl Acad Sci U S A 98: 10469-10474.
26.
Toussaint O, Medrano EE, von Zglinicki T (2000): Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp Gerontol 35: 927-945.
27.
Frippiat C, Dewelle J, Remacle J, Toussaint O (2002): Signal transduction in H2O2-induced senescence-like phenotype in human diploid fibroblasts. Free Radic Biol Med 33: 1334-1346.
28.
Kahlem P, Dorken B, Schmitt CA (2004): Cellular senescence in cancer treatment: friend or foe? J Clin Invest 113: 169-174.
29.
Duan J, Duan J, Zhang Z, Tong T (2005): Irreversible cellular senescence induced by prolonged exposure to H2O2 involves DNA-damage-and-repair genes and telomere shortening. Int J Biochem Cell Biol 37: 1407-1420.
30.
Deicher R, Ziai F, Cohen G, et al. (2003): High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. Kidney Int 64: 728-736.
31.
Kuo KL, Hung SC, Wei YH, Tarng DC (2008): Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. J Am Soc Nephrol 19: 1817-1826.
32.
Effros RB (2000): Long-term immunological memory against viruses. Mech Ageing Dev 121: 161-171.
33.
Effros RB, Boucher N, Porter V, et al. (1994): Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol 29: 601-609.
34.
Spaulding C, Guo W, Effros RB (1999): Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp Gerontol 34: 633-644.
35.
Fagnoni FF, Vescovini R, Mazzola M, et al. (1996): Expansion of cytotoxic CD8+ CD28- T cells in healthy ageing people, including centenarians. Immunology 88: 501-507.
36.
Monteiro J, Batliwalla F, Ostrer H, Gregersen PK (1996): Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J Immunol 156: 3587-3590.
37.
Weng NP, Hathcock KS, Hodes RJ (1998): Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity 9: 151-157.
38.
Valenzuela VF, Effros RB (2002): Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin Immunol 105: 117-125.
39.
Plunkett FJ, Franzese O, Finney HM, et al. (2007): The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation. J Immunol 178: 7710-7719.
40.
Jacinto E, Facchinetti V, Liu D, et al. (2006): SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127: 125-137.
41.
Fauce SR, Jamieson BD, Chin AC, et al. (2008): Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J Immunol 181: 7400-7406.
42.
Gharagozloo M, Bagherpour B, Tahanian M, et al. (2009): Premature senescence of T lymphocytes from patients with beta-thalassemia major. Immunol Lett 122: 84-88.
43.
Gupta A, Zhuo J, Zha J, et al. (2010): Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival. BMC Nephrol 11: 16.
44.
Hentze MW, Muckenthaler MU, Andrews NC (2004): Balancing acts: molecular control of mammalian iron metabolism. Cell 117: 285-297.
45.
Rudeck M, Volk T, Sitte N, Grune T (2000): Ferritin oxidation in vitro: implication of iron release and degradation by the 20S proteasome. IUBMB Life 49: 451-456.
46.
Djeha A, Brock JH (1992): Uptake and intracellular handling of iron from transferrin and iron chelates by mitogen stimulated mouse lymphocytes. Biochim Biophys Acta 1133: 147-152.
47.
Nakazawa H, Genka C, Fujishima M (1996): Pathological aspects of active oxygens/free radicals. Jpn J Physiol 46: 15-32.
48.
Mencacci A, Cenci E, Boelaert JR, et al. (1997): Iron overload alters innate and T helper cell responses to Candida albicans in mice. J Infect Dis 175: 1467-1476.
49.
Cardier JE, Romano E, Soyano A (1997): T lymphocytes subsets in experimental iron overload. Immunopharmacol Immunotoxicol 19: 75-87.
50.
Rubin RB, Barton AL, Banner BF, Bonkovsky HL (1995): Iron and chronic viral hepatitis: emerging evidence for an important interaction. Dig Dis 13: 223-238.
51.
Saretzki G, Von Zglinicki T (2002): Replicative aging, telomeres, and oxidative stress. Ann N Y Acad Sci 959: 24-29.
52.
Jiang H, Braunstein NS, Yu B, et al. (2001): CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice. Proc Natl Acad Sci U S A 98: 6301-6306.
53.
Saurwein-Teissl M, Lung TL, Marx F, et al. (2002): Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 168: 5893-5899.
54.
Goronzy JJ, Fulbright JW, Crowson CS, et al. (2001): Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 75: 12182-12187.
55.
Ciubotariu R, Colovai AI, Pennesi G, et al. (1998): Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28- regulatory T cells. J Immunol 161: 5193-5202.
56.
Henel G, Singh K, Cui D, et al. (2006): Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors. Blood 107: 4449-4457.
57.
Fann M, Chiu WK, Wood WH, et al. (2005): Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging. Immunol Rev 205: 190-206.
58.
Najafian N, Chitnis T, Salama AD, et al. (2003): Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. J Clin Invest 112: 1037-1048.
59.
Dock JN, Effros RB (2011): Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence. Aging Dis 2: 382-397.
60.
Goodwin K, Viboud C, Simonsen L (2006): Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24: 1159-1169.
61.
Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. (1998): Survival and disease complications in thalassemia major. Ann N Y Acad Sci 850: 227-231.
62.
Aksenov MY, Hasselrot U, Bansal AK, et al. (2001): Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neurosci Lett 305: 5-8.
63.
Suresh DR, Annam V, Pratibha K, Prasad BV (2009): Total antioxidant capacity – a novel early bio-chemical marker of oxidative stress in HIV infected individuals. J Biomed Sci 16: 61.
64.
Sundaram M, Saghayam S, Priya B, et al. (2008): Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India. Int J Infect Dis 12: e61-66.
65.
Ngondi JL, Oben J, Forkah DM, et al. (2006): The effect of different combination therapies on oxidative stress markers in HIV infected patients in Cameroon. AIDS Res Ther 3: 19.
66.
Mandas A, Iorio EL, Congiu MG, et al. (2009): Oxidative imbalance in HIV-1 infected patients treated with antiretroviral therapy. J Biomed Biotechnol 2009: 749575.
67.
Kaplan RC, Sinclair E, Landay AL, et al. (2011): T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 203: 452-463.
68.
Kirkham P (2007): Oxidative stress and macrophage function: a failure to resolve the inflammatory response. Biochem Soc Trans 35: 284-287.
69.
Carre N, Deveau C, Belanger F, et al. (1994): Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study Group. AIDS 8: 797-802.
70.
Parola M, Robino G (2001): Oxidative stress-related molecules and liver fibrosis. J Hepatol 35: 297-306.
71.
Valgimigli M, Valgimigli L, Trere D, et al. (2002): Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation. Free Radic Res 36: 939-948.
72.
Lopez-Prieto J, Gonzalez-Reimers E, Aleman-Valls MR, et al. (2013): Iron and proinflammatory cytokines in chronic hepatitis C virus infection. Biol Trace Elem Res 155: 5-10.
73.
Venturini D, Simao AN, Barbosa DS, et al. (2010): Increased oxidative stress, decreased total antioxidant capacity, and iron overload in untreated patients with chronic hepatitis C. Dig Dis Sci 55: 1120-1127.
74.
Kundu D, Roy A, Mandal T, et al. (2012): Oxidative stress in alcoholic and viral hepatitis. N Am J Med Sci 4: 412-415.
75.
Satra M, Dalekos GN, Kollia P, et al. (2005): Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections. J Viral Hepat 12: 488-493.
76.
Bhargava A, Raghuram GV, Pathak N, et al. (2011): Occult hepatitis C virus elicits mitochondrial oxidative stress in lymphocytes and triggers PI3-kinase-mediated DNA damage response. Free Radic Biol Med 51: 1806-1814.
77.
Manfras BJ, Weidenbach H, Beckh KH, et al. (2004): Oligoclonal CD8+ T-cell expansion in patients with chronic hepatitis C is associated with liver pathology and poor response to interferon-alpha therapy. J Clin Immunol 24: 258-271.
78.
Young LS, Rickinson AB (2004): Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-768.
79.
Xia T, O’Hara A, Araujo I, et al. (2008): EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 68: 1436-1442.
80.
Kamranvar SA, Masucci MG (2011): The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress. Leukemia 25: 1017-1025.
81.
Petrova M, Muhtarova M, Nikolova M, et al. (2006): Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients. World J Gastroenterol 12: 5711-5716.
82.
Weng NP, Akbar AN, Goronzy J (2009): CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol 30: 306-312.
83.
Shi B, Raina J, Lorenzo A, et al. (1998): Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J Neurovirol 4: 281-290.
84.
Eylar EH, Lefranc CE, Yamamura Y, et al. (2001): HIV infection and aging: enhanced Interferon- and Tumor Necrosis Factor-alpha production by the CD8+ CD28- T subset. BMC Immunol 2: 10.
85.
Zanni F, Vescovini R, Biasini C, et al. (2003): Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol 38: 981-987.
86.
Olofsson PS (2012): Targeting T cell costimulation to prevent atherothrombosis. Circ Res 110: 800-801.
87.
Butthep P, Rummavas S, Wisedpanichkij R, et al. (2002): Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia. Am J Hematol 70: 100-106.
88.
Glaser R, Litsky ML, Padgett DA, et al. (2006): EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease. Virology 346: 205-218.
89.
Crespo J, Rivero M, Fabrega E, et al. (2002): Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis. Dig Dis Sci 47: 1604-1610.
90.
Biswas SK, McClure D, Jimenez LA, et al. (2005): Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal 7: 32-41.
91.
Muller F, Svardal AM, Nordoy I, et al. (2000): Virological and immunological effects of antioxidant treatment in patients with HIV infection. Eur J Clin Invest 30: 905-914.
92.
Favier A, Sappey C, Leclerc P, et al. (1994): Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact 91: 165-180.
93.
Kugelman A, Choy HA, Liu R, et al. (1994): Gamma-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am J Respir Cell Mol Biol 11: 586-592.
94.
Staal FJ, Ela SW, Roederer M, et al. (1992): Glutathione deficiency and human immunodeficiency virus infection. Lancet 339: 909-912.
95.
Steiner J, Haughey N, Li W, et al. (2006): Oxidative stress and therapeutic approaches in HIV dementia. Antioxid Redox Signal 8: 2089-2100.
96.
Hurwitz BE, Klaus JR, Llabre MM, et al. (2007): Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Arch Intern Med 167: 148-154.
97.
Alidoost F, Gharagozloo M, Bagherpour B, et al. (2006): Effects of silymarin on the proliferation and glutathione levels of peripheral blood mononuclear cells from beta-thalassemia major patients. Int Immunopharmacol 6: 1305-1310.
98.
Neve J (1996): Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk 3: 42-47.
99.
Rayman MP (2000): The importance of selenium to human health. Lancet 356: 233-241.
100.
Sappey C, Legrand-Poels S, Best-Belpomme M, et al. (1994): Stimulation of glutathione peroxidase activity decreases HIV type 1 activation after oxidative stress. AIDS Res Hum Retroviruses 10: 1451-1461.
101.
Look MP, Rockstroh JK, Rao GS, et al. (1997): Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res 56: 31-41.
102.
Campa A, Shor-Posner G, Indacochea F, et al. (1999): Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol 20: 508-513.
103.
Ammann AJ, Abrams D, Conant M, et al. (1983): Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol 27: 315-325.
104.
Brigelius-Flohe R, Banning A (2006): Part of the series: from dietary antioxidants to regulators in cellular signaling and gene regulation. Sulforaphane and selenium, partners in adaptive response and prevention of cancer. Free Radic Res 40: 775-787.
105.
Prasad AS (1996): Zinc: the biology and therapeutics of an ion. Ann Intern Med 125: 142-144.
106.
Wellinghausen N, Kirchner H, Rink L (1997): The immunobiology of zinc. Immunol Today 18: 519-521.
107.
Barbaro G, Di Lorenzo G, Ribersani M, et al. (1999): Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol 30: 774-782.
108.
Boya P, de la Pena A, Beloqui O, et al. (1999): Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C. J Hepatol 31: 808-814.
109.
Lin CC, Liu WH, Wang ZH, Yin MC (2011): Vitamins B status and antioxidative defense in patients with chronic hepatitis B or hepatitis C virus infection. Eur J Nutr 50: 499-506.
110.
Yadav D, Hertan HI, Schweitzer P, et al. (2002): Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. Am J Gastroenterol 97: 2634-2639.
111.
Chvapil M (1976): Effect of zinc on cells and biomembranes. Med Clin North Am 60: 799-812.
112.
Pfeifer W, Degasperi G, Almeida M, et al. (2008): Vitamin E supplementation reduces oxidative stress in beta thalassaemia intermedia. Acta Haematol 120: 225-231.
113.
Villalba JM, Navarro F, Gomez-Diaz C, et al. (1997): Role of cytochrome b5 reductase on the antioxidant function of coenzyme Q in the plasma membrane. Mol Aspects Med 18 Suppl: S7-13.
114.
Bilbis LS, Idowu DB, Saidu Y, et al. (2010): Serum levels of antioxidant vitamins and mineral elements of human immunodeficiency virus positive subjects in Sokoto, Nigeria. Ann Afr Med 9: 235-239.
115.
Djinhi J, Tiahou G, Zirihi G, et al. (2009): Selenium deficiency and oxidative stress in asymptomatic HIV1-infected patients in Cote d’Ivoire. Bull Soc Pathol Exot 102: 11-13.
116.
Srinivas A, Dias BF (2008): Antioxidants in HIV positive children. Indian J Pediatr 75: 347-350.
117.
Chen C, Reddy KS, Johnston TD, et al. (2003): Vitamin E inhibits cyclosporin A and H2O2 promoted Epstein-Barr virus (EBV) transformation of human B cells as assayed by EBV oncogene LMP1 expression. J Surg Res 113: 228-233.
118.
Chiu HJ, Fischman DA, Hammerling U (2008): Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP-1-dependent energy deprivation. FASEB J 22: 3878-3887.
119.
Kassab-Chekir A, Laradi S, Ferchichi S, et al. (2003): Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta 338: 79-86.
120.
Waseem F, Khemomal KA, Sajid R (2011): Antioxidant status in beta thalassemia major: a single-center study. Indian J Pathol Microbiol 54: 761-763.
121.
Gharagozloo M, Karimi M, Amirghofran Z (2013): Immunomodulatory effects of silymarin in patients with beta-thalassemia major. Int Immunopharmacol 16: 243-247.
122.
Bahmani M, Shirzad H, Rafieian S, Rafieian-Kopaei M (2015): Silybum marianum: Beyond Hepatoprotection. J Evid Based Complementary Altern Med 20: 292-301.
123.
Nasri H, Baradaran A, Shirzad H, Rafieian-Kopaei M (2014): New concepts in nutraceuticals as alternative for pharmaceuticals. Int J Prev Med 5: 1487-1499.
124.
Asadi-Samani M, Kafash-Farkhad N, Azimi N, et al. (2015): Medicinal plants with hepatoprotective activity in Iranian folk medicine. Asian Pac J Trop Biomed 5: 146-157.
125.
Niknam S, Ghatreh-Samani K, Farrokhi E (2015): The effect of adiponectin on osteonectin gene expression by oxidized low density lipoprotein-treated vascular smooth muscle cells. Int J Mol Cell Med Winter 4: 60-66.
126.
Farrokhi E, Ghatreh Samani K, Hashemzadeh Chaleshtori M, Tabatabaiefar MA (2015): Effect of oxidized low density lipoprotein on the expression of Runx2 and SPARC genes in vascular smooth muscle cells. Iran Biomed J 19: 160-164.
127.
Nasri H, Shirzad H, Baradaran A, Rafieian-kopaei M (2015): Antioxidant plants and diabetes mellitus. J Res Med Sci 20: 491-502.
128.
Bakhshalizadeh S, Esmaeili F, Houshmand F, et al. (2011): Effects of selegiline, a monoamine oxidase B inhibitor, on differentiation of P19 embryonal carcinoma stem cells, into neuron-like cells. In Vitro Cell Dev Biol Anim 47: 550-557.
129.
Sarrafchi A, Bahmani M, Shirzad H, Rafieian-Kopaei M (2015): Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants. Curr Pharm Des [Epub ahead of print].
Share
RELATED ARTICLE
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
